Most Profitable Pharmaceuticals Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
144.07 B
 0.15 
 1.27 
 0.19 
2NVO Novo Nordisk AS
83.68 B
(0.04)
 2.33 
(0.10)
3RDY Dr Reddys Laboratories
55.68 B
 0.14 
 1.39 
 0.20 
4JNJ Johnson Johnson
13.33 B
 0.23 
 1.07 
 0.24 
5NVS Novartis AG ADR
8.57 B
 0.17 
 1.06 
 0.18 
6BMY Bristol Myers Squibb
8.04 B
 0.12 
 2.16 
 0.27 
7AZN AstraZeneca PLC ADR
6.9 B
 0.03 
 1.15 
 0.03 
8SNY Sanofi ADR
5.4 B
 0.22 
 1.49 
 0.32 
9LLY Eli Lilly and
5.24 B
 0.04 
 2.35 
 0.10 
10GSK GlaxoSmithKline PLC ADR
4.93 B
 0.10 
 1.31 
 0.13 
11ZTS Zoetis Inc
2.34 B
 0.10 
 1.50 
 0.16 
12PFE Pfizer Inc
2.13 B
 0.10 
 1.32 
 0.13 
13RPRX Royalty Pharma Plc
1.13 B
 0.05 
 1.39 
 0.08 
14OGN Organon Co
1.02 B
 0.00 
 2.35 
 0.00 
15JAZZ Jazz Pharmaceuticals PLC
414.83 M
(0.03)
 1.73 
(0.05)
16MRK Merck Company
365 M
(0.10)
 1.79 
(0.17)
17PBH Prestige Brand Holdings
209.34 M
 0.11 
 1.46 
 0.16 
18INVA Innoviva
179.72 M
 0.27 
 1.19 
 0.32 
19AMPH Amphastar P
137.54 M
 0.07 
 2.64 
 0.19 
20HRMY Harmony Biosciences Holdings
128.85 M
 0.16 
 2.45 
 0.40 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.